LinkedIn
WebsiteIntroduction
Arcadia Biosciences Inc. (Nasdaq: RKDA) is a publicly traded agricultural biotechnology company headquartered in Dallas, Texas. Founded in 2002, the company focuses on science-based approaches to enhance crop quality and develop plant-based health and wellness products, including specialty wheat ingredients and Zola® coconut water.
Corporate Structure
Arcadia Biosciences operates with a workforce of 11–50 employees and is listed on the Nasdaq exchange under the ticker RKDA. The company maintains research and development partnerships with major food manufacturers and processors to bring functional food innovations from seed to table.
Agricultural biotechnology by S N Pattenden
Recent Developments and News
On October 15, 2025, RKDA shares closed at $5.42, reflecting a 46.88% increase on a volume of 4,025,821. Key company updates include:
- Business Combination Agreement
Arcadia entered into an all-stock business combination agreement with Roosevelt Resources, a Dallas-based oil and gas company. An investor call was scheduled for December 11, 2024, to discuss the transaction details. - Third Quarter of 2024 Results
For the quarter ended September 30, 2024, total revenues increased 18% year over year. Zola® coconut water revenues grew 55%, and new retail distribution expanded by 68% compared with the prior year. - SEC Filings
- 10-Q filed August 14, 2025, covering the quarter ended June 30, 2025
- Schedule 13G filed August 19, 2025, reporting a 5.08% ownership stake in Above Food Ingredients Inc.
- Form 8-K filed August 29, 2025, under Items 5.02 and 9.01, indicating changes in executive officers and related exhibits (details not yet disclosed).
Financial and Strategic Analysis
Arcadia’s trailing-twelve-month performance reflects continued investment in research, development, and market expansion:
| Metric | Value |
|---|---|
| Stock price (2025-10-15) | $5.42 (+46.88%) |
| Volume | 4,025,821 |
| 52-Week Range | $2.53 – $10.31 |
| Market Capitalization | $5.04 M |
| Revenue (TTM) | $5.41 M |
| Net Income (TTM) | – $7.08 M |
| EPS (TTM) | – $5.19 |
| Cash (mrq) | $4.44 M |
| Total Debt/Equity (mrq) | 0.24% |
| Price/Sales (TTM) | 0.88× |
| Price/Book (mrq) | 1.05× |
The company’s portfolio includes GoodWheat, a reduced-gluten, enhanced-starch wheat variety, and HB4 drought-tolerant soybeans, developed in partnership with Bioceres. These traits aim to address consumer demand for functional foods and resilient crops. Arcadia’s partnerships with major food processors support both ingredient sales and beverage expansion through Zola.
Market Position and Industry Context
Arcadia operates within the agritech and functional food markets. Its specialty wheat ingredients and plant-based beverages compete with agricultural suppliers and food-tech startups. The company’s focus on health-oriented crop traits aligns it with other biotechnology firms pursuing regulatory approvals and commercial opportunities for genetically enhanced seeds. In beverages, Zola® competes within the coconut-water category while demonstrating growth in retail distribution.
tl;dr
RKDA increased by 46.88% on October 15, 2025, closing at $5.42 on substantial volume. Arcadia’s business combination with Roosevelt Resources (investor call on December 11, 2024) and its Q3 2024 revenue increase (18% year-over-year; Zola® up 55%) signify ongoing strategic partnerships. Recent filings (10-Q, Schedule 13G, 8-K) indicate changes in ownership and management structures. Analysts’ 12-month target price is set at $12.00, reflecting potential value from crop-trait development and beverage market expansion.
